In the presence of ROS, it releases its electron and becomes oxidised first into monodehydroascorbate and subsequently to dehydroascorbate
This reflects the state of play as of early 2026: States that cover GLP-1s for obesity treatment (fee-for-service): Arkansas, Colorado, Connecticut, Delaware, Illinois, Louisiana, Massachusetts, Minnesota, New Mexico, New York, Oregon, Virginia, Washington approximately 13 states total as of January 2026
Front Oncol 10:1370
Arlington- serving Tarrant County 2
For some, these medications give people who have struggled with their weight for years a sense of control over their bodies that can lead to lower stress levels and better mental health outcomes
Rheumatology (Oxford) (2016) 55(1):17384